Pdt Partners, LLC Charles River Laboratories International, Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 9,263 shares of CRL stock, worth $1.85 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

9,263

Previous 12,763 27.42%

Holding current value

$1.85 Million

Previous $2.64 Million 30.8%

% of portfolio

0.18%

Previous 0.27%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $657,860 - $858,515	-3,500 Reduced 27.42%	9,263 $1.82 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $28,899 - $38,827	-142 Reduced 1.1%	12,763 $3.46 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $1.19 Million - $1.72 Million	7,205 Added 126.4%	12,905 $3.05 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $758,316 - $848,679	3,900 Added 216.67%	5,700 $1.12 Million
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $330,678 - $378,450	1,800 New	1,800 $378,000
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $2.31 Million - $3.42 Million	11,302 Added 594.84%	13,202 $2.83 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $532,227 - $754,275	-2,083 Reduced 52.3%	1,900 $540,000
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $5.76 Million - $7.36 Million	-16,406 Reduced 80.46%	3,983 $1.5 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $46,580 - $57,287	-125 Reduced 0.61%	20,389 $8.41 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $5.62 Million - $7.1 Million	19,114 Added 1365.29%	20,514 $7.59 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $349,538 - $419,272	1,400 New	1,400 $406,000
Q1 2020 May 15, 2020	SELL	$98.9 - $178.34 $2.34 Million - $4.22 Million	-23,664 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $10.9 Million - $13.2 Million	-86,262 Reduced 78.47%	23,664 $3.62 Million
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $1.27 Million - $1.46 Million	-10,174 Reduced 8.47%	109,926 $14.6 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $1.78 Million - $2.14 Million	14,400 Added 13.62%	120,100 $17 Million
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $1.02 Million - $1.43 Million	-9,739 Reduced 8.44%	105,700 $15.4 Million
Q4 2018 Feb 14, 2019	BUY	$105.09 - $137.23 $4,098 - $5,351	39 Added 0.03%	115,439 $13.1 Million
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $2.33 Million - $2.8 Million	-20,800 Reduced 15.27%	115,400 $15.5 Million
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $1.16 Million - $1.36 Million	-11,511 Reduced 7.79%	136,200 $14.9 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $14.3 Million - $16.1 Million	147,711	147,711 $16 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account